#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
“When we look at the evidence for cannabis in chronic pain, what matters clinically is that we’re finally seeing rigorous data that validates what patients have been telling us for years, and this allows us to move beyond ideology on either side and make real treatment decisions based on outcomes.”
💊 While emerging research suggests cannabis may provide symptom relief for certain chronic pain conditions, clinicians should approach these findings with appropriate caution given the current evidence limitations and heterogeneity in study designs, dosing protocols, and patient populations. The therapeutic potential must be weighed against individual risk factors including psychiatric comorbidities, substance use history, driving safety, and potential drug interactions, particularly in older adults or those on multiple medications. Publication patterns and funding sources in cannabis research merit scrutiny, as positive findings may be overrepresented in the literature compared to null or negative results. For patients with refractory chronic pain where conventional analgesics have failed or pose unacceptable risks, a cautious discussion about cannabis as an adjunctive option may be warranted in jurisdictions where it is legal, with clear documentation of the uncertainty regarding efficacy and safety. Ultimately, individualized assessment and shared decision-making remain essential until higher-quality comparative
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
